EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Afucosylated anti-EBOV antibody MIL77-3 engages sGP to elicit NK cytotoxicity

Yuting Zhang, Min Zhang, Haiyan Wu, Xiaonan Wu, Hang Zheng, Junjuan Feng, Mianjing Wang, Jing Wang, Longlong Luo, He Xiao, Chunxia Qiao, Xinying Li und 6 weitere

Journal of Virology · 2024

DOI: 10.1128/jvi.00685-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Yuting Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology and Toxicology, Beijing, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Ebolavirus, Receptors, IgG, Antibody-Dependent Cell Cytotoxicity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MIL77-3 is one component of antibody cocktail that is produced in our lab and represents an effective regimen for animals suffering from Zaire Ebolavirus (EBOV) infection. MIL77-3 is engineered to increase its affinity for the FcγRIIIa (CD16a) by deleting the fucose in the framework region. The potential effects of this modification on host immune responses, however, remain largely unknown. Herein, we demonstrated that MIL77-3 recognized secreted glycoproptein (sGP), produced by EBOV, and formed the immunocomplex to potently augment antibody-dependent cytotoxicity of human peripheral blood-derived natural killer cells (pNKs), including CD56 dim and CD56 bright subpopulations, in contrast to the counterparts (Mab114, rEBOV548, fucosylated MIL77-3). Intriguingly, this effect was not observed when NK92-CD16a cell line was utilized and restored by the addition of beads-coupled or membrane-anchored sGP in combination with MIL77-3. Furthermore, sGP bound to unrecognized receptors on T cells contaminated in pNKs rather than NK92-CD16a cells. Administration of beads-coupled sGP/MIL77-3 complex in mice elicited NK activation. Overall, this work reveals an immune-stimulating function of sGP/MIL77-3 complex by triggering cytotoxic activity of NK cells, highlighting the necessity to evaluate the potential impact of MIL77-3 on host immune reaction in clinical trials. IMPORTANCE Zaire Ebolavirus (EBOV) is highly lethal and causes sporadic outbreaks. The passive administration of monoclonal antibodies (mAbs) represents a promising treatment regimen against EBOV. Mounting evidence has shown that the efficacy of a subset of therapeutic mAbs in vivo is intimately associated with its capacity to trigger NK activity, supporting glycomodification of Fc region of anti-EBOV mAbs as a putative strategy to enhance Fc-mediated immune effector function as well as protection in vivo . Our work here uncovers the potential harmful influence of this modification on host immune responses, especially for mAbs with cross-reactivity to secreted glycoproptein (sGP) (e.g., MIL77-3), and highlights it is necessary to evaluate the NK-stimulating activity of a fucosylated mAb engaged with sGP when a new candidate is developed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalEbolavirusReceptors, IgGAntibody-Dependent Cell CytotoxicityHemorrhagic Fever, EbolaAntibodies, ViralHumansAnimalsMiceAntibodies, MonoclonalFucoseCell Line

Stichwörter der Autor:innen

ADCCantibody functionebola virusnatural killer cells

Substanzen

Receptors, IgGAntibodies, ViralAntibodies, MonoclonalFucoseFCGR3A protein, human

Autor:innen und Institutionen

  • Institute of Pharmacology and Toxicology, Beijing, China.
  • Joint National Laboratory for Antibody Drug Engineering, Henan University, Kaifeng, China.
  • Inner Mongolia Key Lab of Molecular Biology, School of Basic Medical Sciences, Inner Mongolia Medical University, Hohhot, China.
  • Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control, Beijing, China.
  • Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Yi Wang, Guojiang Chen

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Zhang, Y., Zhang, M., Wu, H., Wu, X., Zheng, H., Feng, J., Wang, M., Wang, J., Luo, L., Xiao, H., Qiao, C., Li, X., Zheng, Y., Huang, W., Wang, Y., Wang, Y., Feng, J., & Chen, G. (2024). Afucosylated anti-EBOV antibody MIL77-3 engages sGP to elicit NK cytotoxicity. Journal of Virology. https://doi.org/10.1128/jvi.00685-24

Vancouver

Zhang Y, Zhang M, Wu H, Wu X, Zheng H, Feng J, et al. Afucosylated anti-EBOV antibody MIL77-3 engages sGP to elicit NK cytotoxicity. Journal of Virology. 2024. doi:10.1128/jvi.00685-24

BibTeX
@article{Zhang2024,
  author = {Zhang, Yuting and Zhang, Min and Wu, Haiyan and Wu, Xiaonan and Zheng, Hang and Feng, Junjuan and Wang, Mianjing and Wang, Jing and Luo, Longlong and Xiao, He and Qiao, Chunxia and Li, Xinying and Zheng, Yuanqiang and Huang, Weijin and Wang, Youchun and Wang, Yi and Feng, Jiannan and Chen, Guojiang},
  title = {Afucosylated anti-EBOV antibody MIL77-3 engages sGP to elicit NK cytotoxicity},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.00685-24}
}
Kostenlos starten →